Ken­vue, Wal­greens and oth­ers named in class ac­tion law­suits over ef­fi­ca­cy of nasal de­con­ges­tant

Sev­er­al man­u­fac­tur­ers of over-the-counter cold med­i­cines have been named in a string of class ac­tion law­suits fol­low­ing an FDA ad­vi­so­ry com­mit­tee’s vote ear­li­er this week that the oral nasal de­con­ges­tant phenyle­phrine is not ef­fec­tive.

The suits were filed in courts across the coun­try against Ken­vue, John­son & John­son’s for­mer con­sumer health unit, Proc­ter & Gam­ble, Bay­er Health­care, GSK Con­sumer Health­care (which re­cent­ly spun off as Ha­le­on), Wal­greens, Wal­mart and oth­ers.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER